This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Il-Yang Pharm. Co., Ltd. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Dangjin-geun, KR (2009)
- Incheon, KR (2009)
Company Filing History:
Years Active: 2009
Certainly! Here is the article about inventor Byoung-Cheol Han:
Title: Unveiling the Innovations of Byoung-Cheol Han in Cancer Treatment
Introduction:
Byoung-Cheol Han, a prolific inventor hailing from Dangjin-geun, South Korea, has made remarkable contributions to the field of pharmaceuticals with his inventive creations. Known for his focus on developing compounds to combat various types of cancers, Han's work has garnered attention for its potential to revolutionize cancer treatment.
Latest Patents:
With a total of two patents under his belt, Byoung-Cheol Han's latest inventions revolve around N-phenyl-2-pyrimidine-amine derivatives and their processes for preparation. These groundbreaking compounds have shown promising effects in treating a spectrum of cancers in warm-blooded animals, including lung cancer, gastric cancer, colon cancer, and more. The pharmaceutical compositions derived from these inventions offer hope for improved therapies against a range of malignant diseases.
Career Highlights:
Han's innovative spirit shines through in his role at Il-Yang Pharm Co., Ltd, a prominent pharmaceutical company where he continues to push the boundaries of drug development. His dedication to pioneering novel solutions for complex medical conditions underscores his commitment to advancing healthcare through innovative means.
Collaborations:
Collaboration lies at the heart of Byoung-Cheol Han's success, with colleagues such as Dong-Yeon Kim and Dae-Jin Cho playing pivotal roles in realizing his inventive ideas. Together, they form a formidable team driving forward advancements in cancer research and drug discovery.
Conclusion:
In conclusion, Byoung-Cheol Han stands as a beacon of innovation in the realm of oncology, with his patents paving the way for novel cancer treatments. His visionary approach to pharmaceutical development underscores the profound impact that inventors like Han can have on revolutionizing healthcare and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile